about
Effects of Blood Pressure Reduction in Mild HypertensionNon-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplastySalt Reduction Initiatives around the World - A Systematic Review of Progress towards the Global TargetEffects of fibrates in kidney disease: a systematic review and meta-analysisA comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review and meta-analysisA shortened verbal autopsy instrument for use in routine mortality surveillance systemsImproving performance of the Tariff Method for assigning causes of death to verbal autopsiesGlobal, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013Comparability of HbA1c and lipids measured with dried blood spot versus venous samples: a systematic review and meta-analysis.Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data.Ambulatory blood pressure adds little to Framingham Risk Score for the primary prevention of cardiovascular disease in older men: secondary analysis of observational study data.Effectiveness of fixed dose combination medication ('polypills') compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countries.Do polypills lead to neglect of lifestyle risk factors? Findings from an individual participant data meta-analysis among 3140 patients at high risk of cardiovascular disease.Estimating population food and nutrient exposure: a comparison of store survey data with household panel food purchases.FoodSwitch: A Mobile Phone App to Enable Consumers to Make Healthier Food Choices and Crowdsourcing of National Food Composition Data.Using mobile technology to support lower-salt food choices for people with cardiovascular disease: protocol for the SaltSwitch randomized controlled trial.Effects of interpretive front-of-pack nutrition labels on food purchases: protocol for the Starlight randomised controlled trialUse of Smartphone for Verbal Autopsy.Effects of interpretive nutrition labels on consumer food purchases: the Starlight randomized controlled trial.The Sodium Content of Processed Foods in South Africa during the Introduction of Mandatory Sodium Limits.Optimizing the analysis strategy for the CANVAS Program: A prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trialsFollow-up of blood-pressure lowering and glucose control in type 2 diabetes.An evaluation of the effects of the Australian Food and Health Dialogue targets on the sodium content of bread, breakfast cereals and processed meatsOmega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis.Protocol for developing the evidence base for a national salt reduction programme for IndiaBlood pressure lowering in type 2 diabetes: a systematic review and meta-analysis.Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.The association of knowledge, attitudes and behaviours related to salt with 24-hour urinary sodium excretion.Effects of the endpoint adjudication process on the results of a randomised controlled trial: the ADVANCE trialInternet-delivered cognitive behavioural therapy for adults with mild to moderate depression and high cardiovascular disease risks: a randomised attention-controlled trial.Evaluation of the dual peroxisome proliferator-activated receptor α/γ agonist aleglitazar to reduce cardiovascular events in patients with acute coronary syndrome and type 2 diabetes mellitus: rationale and design of the AleCardio trial.Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial.Impact of the UK voluntary sodium reduction targets on the sodium content of processed foods from 2006 to 2011: analysis of household consumer panel data.Population impact of a high cardiovascular risk management program delivered by village doctors in rural China: design and rationale of a large, cluster-randomized controlled trial.Protocol for the implementation and evaluation of a community-based intervention seeking to reduce dietary salt intake in Lithgow, Australia.The Sleep Apnea cardioVascular Endpoints (SAVE) Trial: Rationale, Ethics, Design, and Progress.Protocol for a cluster-randomised trial to determine the effects of advocacy actions on the salt content of processed foodsEffects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis.A Comparison of the Sodium Content of Supermarket Private-Label and Branded Foods in Australia.
P50
Q22305300-D837CC22-4CE8-4123-A2DD-67963DC26206Q24200252-5A3F59B3-26A4-480A-A45D-843111BD1911Q26800953-B4536CE7-0A5B-414C-A16E-63421FC6832CQ27008473-08E68212-2B61-4170-9288-A61DDB83162AQ27860879-B6DCD0FD-17B1-4D3F-B234-CCB3C1BE90ADQ28482437-9A0605E6-1872-41A7-9272-90FA9AA81A8BQ28604125-E1ECCAC9-37FB-45EE-B3B0-8B14C8DD5FB6Q28606610-BE086B70-F58E-4966-A158-7D7297A1B68CQ30358426-85B395BA-5E0A-4E94-BFB2-06E22C6AC357Q30583919-5CF66225-A6EF-492B-BD57-DB5091614984Q30843316-97C216BB-506E-426A-B9E4-CC98AE4B04A2Q30848584-453AE6E8-0246-44EC-B069-B7E134AD6F36Q31035256-352E0D31-E1D1-41C5-B357-E98183CDF89EQ31053249-6C5DFBE5-5B5F-460A-B4D0-C5F92DE32F2EQ31070000-1F1380EA-970F-408D-9022-9BDD224D1356Q33441522-F7C7DCEF-C610-429E-A509-56092AF76F52Q33441676-1877E1EB-559A-4631-8C60-EBC0BFE1A77AQ33441695-ABEF915D-0363-4996-9FF5-D07405C084A7Q33450641-2208F78D-B00B-40D9-BD61-6244253504A5Q33452556-FA65B41E-2FC4-4F55-BA1A-DE126E8BC092Q33616969-FB452418-4F3E-49FF-8B8E-5F74EEF8E4D9Q33835824-8F65FE34-F050-442F-A6FC-C1CE60E4DBD3Q34042084-3CA023A1-5C43-4C23-A4B9-143EC8068C57Q34263568-DC755B26-BEC0-47AB-A0FA-35C55017FEC6Q34308961-96804577-A307-47C7-BCB0-CBC335D083A4Q34417219-FA13A75D-9FE9-4B5F-8D0A-07B86431FA3AQ34462095-9FCCA75B-5545-4F3F-97AB-B11B13E76602Q34501392-B56DA29D-D55B-468F-BC87-FF004B70DB84Q34524005-506E9AA4-8CFB-42AD-838D-F42A59E821C1Q34580159-AEC99720-5A01-4246-BB95-C29E17DBA884Q34650792-226D9CB4-92D9-47A2-AB36-5BCB60431DDFQ34655950-C898C522-E249-40CA-8ADC-026DCD11A840Q34660831-8269693D-E54B-4369-B35A-DA582CAC7749Q34953871-7A689BDE-62FC-4CF0-B719-063AC6A9A22FQ35144775-365CE3CE-F2ED-4CB6-AFCC-3C87DF2CB8F4Q35147333-55ACB4E1-2BE1-4731-ABF9-C0F6C1870956Q35866941-64FA3A6D-2B1B-4A39-A51E-468A405FC0DBQ35904167-3D265CB2-DE03-477C-AB43-0FAA5FE5C135Q35968414-3305313C-4795-4593-9E07-CD67806537CBQ36012475-3347700D-8474-4E76-85C8-536278A6FB7E
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Bruce Neal
@ast
Bruce Neal
@en
Bruce Neal
@es
Bruce Neal
@nl
Bruce Neal
@sl
type
label
Bruce Neal
@ast
Bruce Neal
@en
Bruce Neal
@es
Bruce Neal
@nl
Bruce Neal
@sl
prefLabel
Bruce Neal
@ast
Bruce Neal
@en
Bruce Neal
@es
Bruce Neal
@nl
Bruce Neal
@sl
P108
P106
P108
P21
P31
P496
0000-0002-0490-7465